Cytokinetics Presents New MAPLE-HCM Data at AHA 2025, Strengthening Pipeline in Rare Cardiomyopathy Therapy
San Francisco, November 10, 2025 — Cytokinetics, Inc., a biopharmaceutical company focused on developing muscle biology–driven therapies, announced the...
